Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study

INTRODUCTION: To assess the long-term safety and efficacy of subcutaneous tocilizumab (TCZ-SC) in US patients with rheumatoid arthritis (RA) who rolled over from the two global phase 3 studies, SUMMACTA (NCT01194414) and BREVACTA (NCT1232569), into this open-label, single-arm, phase 3b study. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Kivitz, Alan, Wallace, Thomas, Olech, Ewa, Borofsky, Michael, Devenport, Jenny, Pei, Jinglan, Michalska, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127967/
https://www.ncbi.nlm.nih.gov/pubmed/27747585
http://dx.doi.org/10.1007/s40744-016-0043-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127967/
https://www.ncbi.nlm.nih.gov/pubmed/27747585
http://dx.doi.org/10.1007/s40744-016-0043-1

Ejemplares similares